Skip to content

Current shortage

CYSTAGON mercaptamine (cysteamine) (as bitartrate) 150mg capsule bottle

mercaptamine (cysteamine) bitartrate · 441.72 mg Capsule, hard

Supply impact started
8 July 2026
Supply impact ends
31 Jan 2027
TGA row last updated
23 Sept 2026
ARTG ID
60452
Sponsor
Alphapharm Pty Ltd
Sponsor phone
1800274276
Shortage impact
Critical
Availability
Emergency Supply Only

Reason reported to TGA

Manufacturing

TGA management action

An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals.

What to do

  1. 1.
    Contact your pharmacist — Your pharmacist can check stock and whether another pharmacy can supply this product.
  2. 2.
    Ask your doctor before switching — A prescriber can decide whether another product is appropriate. Do not change medicines on your own.
  3. 3.
    Check the TGA report — The TGA Medicine Shortage Reports Database is the source for the dates and management action on this page.

Official sources

Last updated from the TGA Medicine Shortage Reports Database (report generated 12 November 2026 10:24:39 PM).

TGA Medicine Shortage Reports Database

PBS schedule — mercaptamine (cysteamine) bitartrate

MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.